India’s Torrent Pharma misses Q3 profit estimates, hurt by insulin plant closure
(Reuters) – India’s Torrent Pharmaceuticals reported a smaller-than-expected third-quarter profit on Friday, hurt by the planned closure of its insulin manufacturing facility. The company, known for its calcium supplement Shelcal 500, reported a near 14% rise in consolidated net profit to 5.03 billion rupees ($58.3 million) for the quarter ended Dec. 31, missing analysts’ estimates …
India’s Torrent Pharma misses Q3 profit estimates, hurt by insulin plant closure Read More »






